ATAI Stock Analysis: Buy, Sell, or Hold?
ATAI - ATAI Life Sciences N.V. Common Shares
$3.84
0.08 (2.13%)
▲
5d:
-1.54%
30d:
-6.11%
90d:
-33.56%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Mar 16, 2026
Smart Money Accumulation
ATAI is down 9.4% this week, but smart money is accumulating calls. Top strike: $4 2026-03-20 with 674 OI. Call ratio: 99% View Scanner →
Strength: 9.6/10
Get Alerted When ATAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ATAI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ATAI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ATAI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ATAI is currently trading at $3.84, which is considered fair relative to its 30-day fair value range of $3.75 to $4.01.
Technical Outlook: Technically, ATAI is in a strong uptrend. Immediate support is located at $3.50, while resistance sits at $4.17.
Market Sentiment: ATAI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.27 (+219.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ATAI is in a strong uptrend. Immediate support is located at $3.50, while resistance sits at $4.17.
Market Sentiment: ATAI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.27 (+219.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$3.75 -
$4.01
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 219.6% below Wall St target ($12.27)
Fair Price Analysis
30-Day Fair Range
$3.75 -
$4.01
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$3.50
Resistance Level
$4.17
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-7.87
Wall Street Target
$12.27
(+219.6%)
Revenue Growth (YoY)
1772.5%
Earnings Growth (YoY)
-96.8%
Last updated: February 03, 2026 7:43 AM ET
Data refreshes hourly during market hours. Next update: 8:43 AM
Data refreshes hourly during market hours. Next update: 8:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$217 | 54 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 59 HOLD |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
